Eli Lilly and Co (LLY)
786.23
-25.58
(-3.15%)
USD |
NYSE |
Nov 14, 16:00
773.47
-12.76
(-1.62%)
Pre-Market: 09:28
Eli Lilly Unrealized Gain or Loss - Total (Quarterly)
Unrealized Gain or Loss - Total (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Unrealized Gain or Loss - Total (Quarterly) Data
| Date | Value |
|---|
Unrealized Gain or Loss Definition
Unrealized Gain or Loss is the change in value of the assets or liabilities held by a company that haven't yet been realized through a transaction. These gains or losses are present on a company's balance sheet but have not resulted from an actual sale. A positive Unrealized Gain or Loss value indicates that the company holds assets that have appreciated in value but have not yet be realized. A negative Unrealized Gain or Loss indicates that the company holds an asset or investment whose valu...
Unrealized Gain or Loss - Total (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Unrealized Gain or Loss - Total (Quarterly) Benchmarks
| Amgen Inc | -- |
| Biogen Inc | -- |
| Johnson & Johnson | -- |
| Viking Therapeutics Inc | -- |
| Moderna Inc | -- |